Personalized screening for cancers: should we consider polygenic profiling?
about
Cancer prevention: state of the art and future prospectsConstructing Hypothetical Risk Data from the Area under the ROC Curve: Modelling Distributions of Polygenic Risk.An epidemiological perspective of personalized medicine: the Estonian experience.Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis.Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.
P2860
Personalized screening for cancers: should we consider polygenic profiling?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Personalized screening for cancers: should we consider polygenic profiling?
@en
Personalized screening for cancers: should we consider polygenic profiling?
@nl
type
label
Personalized screening for cancers: should we consider polygenic profiling?
@en
Personalized screening for cancers: should we consider polygenic profiling?
@nl
prefLabel
Personalized screening for cancers: should we consider polygenic profiling?
@en
Personalized screening for cancers: should we consider polygenic profiling?
@nl
P2860
P356
P1476
Personalized screening for cancers: should we consider polygenic profiling?
@en
P2093
P2860
P356
10.2217/PME.13.46
P407
P577
2013-08-01T00:00:00Z